RBM-007, an RNA aptamer designed to target fibroblast growth factor 2 (FGF2), is currently in Phase II clinical trials for treating neovascular AMD (nAMD)
Gelinas R, Dontaine J, Horman S, Beauloye C, Bultot L, Bertrand L (2018) AMP-activated protein kinase and O-GlcNAcylation, two partners tightly connected to regulate key cellular processes
DOI: 10.1038/s41598-017-01078-8 Casarini L & Simoni M (2018) Two Hormones for One Receptor: Evolution, Biochemistry, Actions and Pathophysiology of LH and hCG Endocr Rev 39(5):549592
The product he suggests through The Ultimate Human is a CJC-1295 7.5 mg + Ipamorelin 15 mg injectable blend via Peptual
The goal is not to make a complicated chart
doi: 10.1038/s41467-021-24348-6, 26